Supplementary figure 1. Nucleus/cytoplasm fluorescence intensity of AhR in HepG2 treated with DMSO at 0.1% (v/v) as Cont, TCDD 1nM, GI 10 µM or GII 10 µM for 24 h. Fluorescence intensity in nucleus and cytoplasm of in total 3074 cells distributed in the four treatments was measured using the software ImageJ from two independent experiments. For each experiment, nucleus/cytoplasm intensity of treated conditions is presented in fold change compared with nucleus/cytoplasm intensity of Cont condition. Data is represented as the mean ± SD.
Supplementary figure 3. Glyceollins activate aryl hydrocarbon receptor (AhR) bound to XREcontaining CYP1A1. AhR-mediated transcriptional activity was analyzed by transfecting cells with an XRE-CYP1A1 promoter pHu-1A1-FL luciferase reporter plasmid and a CMV-β-galactosidase plasmid as a control for transfection efficiency. MCF-7 cells were treated for 24 h with DMSO at 0.1% (v/v) (white) to serve as the control (Cont), TCDD (black) at 1 nM or two different concentrations of GI (green) and GII (blue), alone or in combination with 1 µM CH223191 (CH), an AhR antagonist. The results are expressed as the fold change in luciferase activity compared with that in the control and are represented as the mean ± SD. The experiment was done 3 times in triplicate. Statistical analyses were performed with one-way ANOVA followed by Dunnett's post hoc test. * p-value < 0.05, *** pvalue < 0.001 are considered to be significantly different with the control group. . (A, D) The differentially expressed genes for each treatment were selected in comparison to the control levels. Then all probes with an intensity signal greater than the overall median and a fold change ≥ 1.5 were selected. The genes were then grouped together and subjected to a LIMMA test; and only those probes with a pvalue ≤ 0.05 were retained, resulting in a total of 237 differentially expressed genes for MCF-7 cells (A) and 83 differentially expressed genes for MDA- MB-231 cells (D). (B, E) 
